Tempo Therapeutics Announces Appointment of Eric I. Richman to Board of Directors
Tempo Therapeutics, IncTempo Therapeutics, Inc. ("Tempo"), a leading innovator in tissue engineering and regenerative medicine, today announced the addition of Eric I. Richman, MBA to its board of directors.